SION · Sionna Therapeutics, Inc.

$44.78 -1.78 (-3.81%) At close · Jul 29

Market Cap

$2.10B

45.15M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Net Income

-$75.27M

FY2025

Diluted EPS

-$1.88

FY2025

Operating Cash Flow

-$66.3M

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	TTM	FY2025
Research & Development	$65.56M	$60.26M
General & Administrative	$33.36M	$28.72M
Total Operating Expenses	$98.92M	$88.98M
Operating Income	-$98.92M	-$88.98M
Interest Income	$13.12M	$13.3M
Other Non-Operating Income	$13.36M	$13.71M
Income Tax	—	$0
Net Income	-$85.57M	-$75.27M
Comprehensive Income	-$85.95M	-$75.1M
EPS (Basic) USD/shares	—	-$1.88
EPS (Diluted) USD/shares	—	-$1.88
Shares Outstanding (Basic Avg) shares	—	39.96M
Shares Outstanding (Diluted Avg) shares	—	39.96M

Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

—

Peer median 6.32×

EV/EBIT

—

Peer median 17.62×

P/E (TTM)

—

Peer median 16.27×

Peer medians compare against the 247 similar-size Biotechnology companies (of 522 listed).

Key facts CIK 2036042 CUSIP 829401108 13F (30d) 13 filings 13 filers Visit website Investor relations